Lehmann Johannes J

Show results for

Unknown (30)
Genomics (5)
Transcriptomics (2)
Proteomics (2)
Models (1)
Metabolomics (1)

Organisms

Homo sapiens (5)
Mus musculus (2)
Alphavirus (2)
Betaherpesvirinae (2)
Brassica oleracea var. oleracea (2)
Cowpox virus (2)
Coxsackievirus (2)
Cytomegalovirus (2)
Dengue virus (2)
EFO:0001352 (2)
Filoviridae (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Human immunodeficiency virus 1 (2)
Human immunodeficiency virus 2 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus (2)
Japanese encephalitis virus group (2)
Lyssavirus rabies (2)
Monkeypox virus (2)
Mus musculus (2)
Nostoc sp. PCC 7120 = FACHB-418 (2)
Oropouche virus (2)
Orthopoxvirus (2)
Orthopoxvirus vaccinia (2)
Rattus (2)
Ruditapes decussatus (2)
Tick-borne encephalitis virus (2)

Repository

EGA (5)
biostudies-arrayexpress (2)
pride (2)
BioModels (1)
MetaboLights (1)

Tissue

Blood plasma (2)

Disease

Extrapulmonary tuberculosis (1)
Focal segmental glomerulosclerosis (1)
Lymph node tuberculosis (1)
Pulmonary tuberculosis (1)

Technology Type

Mass Spectrometry (2)
Mass spectrometry (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2022 (2)
2023 (1)
2014 (1)
2013 (1)
2026 (1)

CHEBI ID

CHEBI:137604 (1)
CHEBI:85851 (1)
CHEBI:66862 (1)
CHEBI:65302 (1)
CHEBI:134270 (1)
CHEBI:134271 (1)
CHEBI:64431 (1)
CHEBI:64519 (1)
CHEBI:64525 (1)
CHEBI:64526 (1)
CHEBI:64446 (1)
CHEBI:64504 (1)
CHEBI:66857 (1)
CHEBI:85766 (1)
CHEBI:64517 (1)
CHEBI:86472 (1)
CHEBI:66849 (1)
CHEBI:66850 (1)
CHEBI:134451 (1)
CHEBI:64516 (1)
CHEBI:65303 (1)
CHEBI:64433 (1)
CHEBI:66848 (1)
CHEBI:64523 (1)
CHEBI:134487 (1)
CHEBI:65294 (1)

Metabolite Name

Phosphatidylethanolamine(38:4) (1)
Phosphatidylethanolamine(36:4) (1)
Phosphatidylethanolamine(36:1) (1)
Phosphatidylcholine(40:8) (1)
Phosphatidylcholine(40:6) (1)
Phosphatidylcholine(40:4) (1)
Phosphatidylcholine(38:6) (1)
Phosphatidylcholine(38:5) (1)
Phosphatidylcholine(38:4) (1)
Phosphatidylcholine(38:3) (1)
Phosphatidylcholine(36:5) (1)
Phosphatidylcholine(36:3) (1)
Phosphatidylcholine(36:2) (1)
Phosphatidylcholine(36:1) (1)
Phosphatidylcholine(35:2) (1)
Phosphatidylcholine(34:1) (1)
Phosphatidylcholine(34:2) (1)
Phosphatidylcholine(33:5) (1)
Phosphatidylcholine(32:2) (1)
Phosphatidylcholine(32:1) (1)
Phosphatidylcholine(32:0) (1)
Phosphatidylcholine(31:0) (1)
Phosphatidylcholine(30:1) (1)
Phosphatidylcholine(33:1) (1)
Phosphatidylcholine(30:0) (1)
Phosphatidylcholine(28:0) (1)

IsPrivate

False (1)

Modelling Approach

Ordinary differential equation model (1)

Study type

Transcription profiling by array (2)

Release Date

2025 (6)
2017 (5)
2021 (4)
2024 (3)
2023 (3)
2019 (2)
2014 (1)
2013 (1)
2026 (1)
2022 (1)
2020 (1)
2016 (1)
2015 (1)
2012 (1)
2007 (1)

Lab affiliation

Department of Preclinical Development and Validation, Fraunhofer Institut for Cell Therapy and Immunology IZI, Leipzig, Germany (1)
Fraunhofer Institute for Cell Therapy and Immunology IZI, Department Preclinical Development and Validation, Proteomics Unit, Leipzig, Germany (1)

Previous page
1 / 5
You're on page 1
page 2
page 3
page 4
page 5
Next page

Sort by:

Relevance

Page size

Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL.

Not available

S-EPMC9980455 | biostudies-literature

ModiDeC: a multi-RNA modification classifier for direct nanopore sequencing.

Not available

S-EPMC12276011 | biostudies-literature

Fatty acid oxidation protects cancer cells from apoptosis through increasing mitochondrial membrane lipids

Overcoming resistance to chemotherapies remains a major unmet need for cancers such as triple negative breast cancer (TNBC). Therefore, mechanistic studies to provide insight for drug development are urgently needed to overcome TNBC therapy resistance. Recently, an important role of fatty acid β-...

2022-05-31 | MTBLS4709 | MetaboLights

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis.

Not available

S-EPMC5424577 | biostudies-literature

Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.

Not available

S-EPMC5347776 | biostudies-literature

Predictors of response and survival in cemiplimab-treated cutaneous squamous cell carcinoma: multicenter real-world evidence from Germany.

Not available

S-EPMC12936293 | biostudies-literature

IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients.

Not available

S-EPMC6627083 | biostudies-literature

Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1.

Not available

S-EPMC8616194 | biostudies-literature

Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.

Not available

S-EPMC2189719 | biostudies-literature

Protein composition of circulating exosomes depend on tuberculosis disease state

Tuberculosis (TB) is a contagious disease that is a primary cause of mortality and illness in around a quater of the world' population particular in low income nations. The disease most commonly affects lung, but pathogens can also be found in other parts of the body. Mycobacterium tuberculosis (Mtb...

ORGANISM(S): Homo sapiens (Human) Mycobacterium tuberculosis

2022-05-20 | PXD030883 | Pride

Previous page
1 / 5
You're on page 1
page 2
page 3
page 4
page 5
Next page

Sort by:

Relevance

Page size

41 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

IsPrivate

Modelling Approach

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets